December 04, 2020 19:51 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GHMC vote counting: TRS takes comfortable lead, BJP lags behind AIMIM | Mamata Banerjee speaks with protesting farmers lending support to farmers' protest | Coronavirus vaccine to be ready in next few weeks: PM Modi | India reports over 36,000 Covid-19 cases in 24 hours, 540 deaths | Three Bengal doctors, including Sagore Dutta Hospital's principal Hasi Dasgupta, succumb to COVID-19 in a single day
Trials of Covid-19 vaccine Sputnik V begin in India Covid-19 Vaccine
Image Credit: UNI

Trials of Covid-19 vaccine Sputnik V begin in India

India Blooms News Service | @indiablooms | 23 Oct 2020, 01:56 pm

New Delhi/UNI: Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organization's Drug Controller General (DCGI) has said.

The organisation has granted permission for conducting the tests to pharmaceutical giant Dr Reddy's Laboratories.

The date and timing of the testing will be determined by the company, the DCGI said.

The vaccine will be tested in the second phase of its clinical trials before moving on to phase 3.

Last week, the Russian Direct Investment Fund (RDIF) and Dr Reddy's said that they had received approval from the DCGI to conduct phase 2 and 3 of clinical trials of Sputnik V. The RDIF and Dr Reddy's have entered into a partnership to supply the Indian company with 100 million doses of Sputnik V in September.

On Monday, the RDIF and another Indian pharmaceutical company, Mankind Pharma, signed an agreement for the marketing and distribution of Sputnik V.

Russia registered the world's first coronavirus vaccine, developed by the Gamaleya Institute together with RDIF, in August. The fund has been teaming up with partners to conduct Sputnik V clinical trials in Belarus, Venezuela and the United Arab Emirates.